IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,000 | -40.0% | 22,997 | +11.7% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 20,585 | +8.1% | 0.00% | – |
| Q1 2016 | $6,000 | +20.0% | 19,049 | +24.1% | 0.00% | – |
| Q4 2015 | $5,000 | -95.5% | 15,353 | -93.3% | 0.00% | – |
| Q1 2015 | $112,000 | -11.8% | 230,136 | +32.3% | 0.00% | – |
| Q4 2014 | $127,000 | -11.8% | 173,932 | +7.7% | 0.00% | – |
| Q3 2014 | $144,000 | -25.8% | 161,512 | -6.8% | 0.00% | – |
| Q2 2014 | $194,000 | -5.4% | 173,242 | +2.9% | 0.00% | – |
| Q1 2014 | $205,000 | +49.6% | 168,290 | +13.8% | 0.00% | – |
| Q4 2013 | $137,000 | -62.4% | 147,863 | +4.4% | 0.00% | – |
| Q3 2013 | $364,000 | +36.3% | 141,673 | +3.1% | 0.00% | – |
| Q2 2013 | $267,000 | – | 137,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
| Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
| Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
| CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
| DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
| OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |